Your browser does not support iframes or is currently configured to not display iframes.

Optical sensors measure blood glucose through the skin Swiss research institute Empa and Zurich University Hospital have developed an optical sensor that can measure blood glucose levels through the skin without taking blood. January 23, 2015

DNA Electronics acquired nanoMR semiconductor DNA sequencing technology for US$24 million. DNA Electronics Ltd. has completed the acquisition of nanoMR Inc., a company in Albuquerque that develops a system for rapidly separating rare cells from blood. The price is about 24 million U.S. dollars.

ICR develops avatars to display important cancer cell characteristics to aid diagnosis. The London Institute of Cancer Research has developed new software to visualize the data generated by cancer cell imaging in a more intuitive way than graphs or charts. A program called PhenoPlot generates "incarnations" of cancer cells based on imaging data collected by a robotic microscope. January 12, 2015

The Massachusetts Center for Life Sciences awarded Cambridge Consultants $1 million to develop an Ebola diagnostic kit for Ebola. January 5, 2015

Portable hematology analyzer can detect the Ebola virus in 75 minutes STMicroelectronics and Clonit have collaborated with Lazzaro Spallanzani, the Italian National Institute of Infectious Diseases, to develop a prototype portable analyzer within a few weeks that can be used in less than 75 minutes Within a period of time, the presence of the Ebola virus was recognized. December 12, 2014

Prostate cancer was diagnosed from tissue samples in 90 seconds. The Fraunhofer Institute for Ceramic Technology and Systems (IKTS) in Dresden has developed a device that can excite fluorescence in a minute and a half by using a laser. Cancerous prostate tissue was identified from the biopsy. November 14, 2014

OJ Bio develops prototype handheld disease diagnosis laboratory Newcastle company OJ Bio has successfully completed the prototype development of a portable wireless instant diagnostic system that can accurately and quickly identify the presence of a series of viruses and bacteria in a patient's body fluid samples. November 7, 2014

FIND and QuantuMDx collaborate to develop a genome-based rapid diagnosis of tuberculosis. The Swiss non-governmental organization FIND is working with the British diagnostic developer QuantuMDx Group to develop a combined solution for rapid tuberculosis detection and drug resistance determination.

A new method of creating biosensors on silicon chips. Scientists from Chile and Germany have developed a new process to layer two ready-made chemicals on a silicon substrate to simulate cell membranes and connect biological processes with electronic devices. . October 30, 2014

Welch Allyn adds Gentag's NFC wireless technology to medical devices Medical diagnostic equipment companies Welch Allyn and Gentag (the pioneers of disposable wireless biosensors) have reached an agreement to bring near field communication technology for medical devices and sensors to the market 2014 October 29

The sound produced by the knee joint shows the degree of osteoarthritis. A team led by Lancaster University has developed a technique that uses sound waves and computer software to assess the state of knee joint osteoarthritis. October 29, 2014

Lung cancer can sleep for 20 years until it is triggered by a genetic defect. Researchers at Cancer Research UK have found that lung cancer can sleep for more than 20 years, until the genetic defect triggers slice growth and the cancer becomes aggressive. October 13, 2014

According to research by Lund University in Sweden, genetic testing can identify people at higher risk of atrial fibrillation and stroke. October 13, 2014

Paris Public Hospital Group and Magnisense cooperate to develop cardiovascular disease detection French hospital group AP-HP (Assistance Publique-Hôpitaux de Paris) and diagnostic technology developer Magnisense signed a cooperation agreement to develop a rapid and portable diagnostic test for cardiovascular disease. October 9, 2014

QuantuMDx announced the launch of a prototype handheld laboratory for rapid DNA diagnosis. The QuantuMDx Group, a medical device developer located in Newcastle, announced the successful production of their first fully integrated sample-to-result Q-POC working prototype, which is a DNA-based The hand-held laboratory of medical diagnosis in minutes. September 11, 2014

New technology for detecting prostate cancer A group of researchers from Guangdong Medical College in China demonstrated the potential of a new test for detecting prostate cancer that combines surface-enhanced Raman scattering (SERS) with a new technology called support vector machine (SVM). September 9, 2014

Roche launches automated molecular diagnostic systems for blood and plasma screening Roche has launched two integrated automated molecular detection systems for blood and plasma donor screening, cobas 6800 and 8800, based on the Nobel Prize-winning PCR technology. September 2, 2014

The hemostatic management equipment approved by NICE for use in the Afghan theater is now recommended by NICE for NHS use. August 29, 2014

Primerdesign announced the launch of the lowest-cost DNA analysis equipment for health, veterinary, food and biological threat testing. Primerdesign Ltd, a spin-off company of the University of Southampton, announced the launch of what it claims is the world’s most affordable DNA diagnostic equipment. Genesig q16 uses real-time PCR analysis, using more than 400 detection kits to detect DNA

Rapid Biosensor Systems appoints chairman for IPO Cambridge company Rapid Biosensor Systems Ltd has appointed John Reynolds OBE as executive chairman to take it to the next stage of growth. August 12, 2014

KTH designed a device to classify cells based on elastic properties. Researchers at KTH Royal Institute of Technology in Sweden used computational simulation to propose a microfluidic device that can classify cells based on their elasticity. This can provide a more reliable alternative for detecting disease biomarkers. July 14, 2014

Plasma biosensor manufactures high-sensitivity diagnostic equipment. A new type of high-sensitivity and low-cost sensor, called plasma biosensor, can detect a series of biomarkers for early diagnosis of diseases. July 8, 2014

Clearbridge BioMedics launches a device for separating circulating tumor cells from blood. Clearbridge BioMedics has launched a new cancer diagnostic device, the ClearCell FX system, which can separate and capture circulating tumor cells (CTC) from blood samples. June 5, 2014

QuantuMDx completes $8.42 million in financing for the prototype design of a handheld DNA diagnostic device. The Newcastle-based diagnostic developer announced that it has completed a $8.42 million financing jointly conducted with philanthropist private investors and the University of Newcastle upon Tyne. June 4, 2014

MRI-guided brain cancer biopsy improves diagnosis. Neurosurgeons at the University of California San Diego Heath System combined real-time MRI technology with non-invasive cell mapping technology to develop a new biopsy method that can improve the accuracy of brain cancer diagnosis . May 6, 2014

ValiRx Cancer Screening Gene Biomarker Receives Japanese Patent ValiRx Plc announced that its cancer screening test gene biomarker NAV3 has received patent approval from the Japan Patent Office (JPO). May 6, 2014

Nanosensors detect cancer through breathing. Researchers from Switzerland and Japan have developed a portable cancer detection device that uses coated nano cantilever beams for respiratory diagnosis. April 25, 2014

Codasip has received US$2.8 million in investment for Codasip, a developer of ASIP technology-specific application processors, and announced that it has completed the first round of public financing from the Czech venture capital company Credo Ventures. April 25, 2014

Blood tests can predict Alzheimer's disease three years before symptoms appear. A group of US researchers are applying for a patent for a blood test based on 10 disease-related lipid biomarkers for Alzheimer's disease. Or mild cognitive impairment (MCI). March 10, 2014

Siemens Medical Diagnostics cooperates with Pfizer to develop diagnostic tests. Siemens Medical Diagnostics and Pfizer are cooperating to develop in vitro diagnostic tests for Pfizer's entire pipeline of therapeutic products. February 4, 2014

QuantuMDx launches a crowdfunding campaign to help a handheld laboratory DNA diagnostic company eliminate malaria QuantuMDx will launch an Indiegogo crowdfunding campaign to support the global eradication of malaria through further development and trials of its handheld laboratory that can identify malaria DNA within 15 minutes. January 9, 2014

University of Surrey device recognizes cancer cells by electrical characteristics A research team at the University of Surrey has developed an innovative device that can distinguish between normal and unhealthy cells by analyzing their electrical characteristics. January 3, 2013

Ultrasonic microscope uses acoustic profile to identify cancerous tissues. Professor Naohiro Hozumi of Toyohashi Institute of Technology has developed an ultrasound microscope to distinguish living tissues and cell specimens for medical purposes. January 3, 2013

QuantuMDx CEO receives OBE in the New Year Honor Roll Elaine Warburton, CEO and co-founder of QuantuMDx Group, was awarded an OBE in the 2014 New Year Honor Roll for her service to health innovation over the past 25 years. January 3, 2013

Finding RNA biomarkers for prostate cancer and other diseases The RIBOLUTION project in Germany is developing a platform for identifying and verifying RNA biomarkers for prostate cancer and selected diseases based on genome screening. December 19, 2013

Paper diagnostic test and mobile phone application to check whether children are vaccinated Cambridge Consultants is working with the American non-profit organization Diagnostics For All to showcase a mobile application that can read a simple paper test to determine whether a child has vaccination. December 11, 2013

The device can measure the risk of blood drop infection in a few minutes. A team at the BioMEMS Resource Center at Massachusetts General Hospital has developed a device that can quickly detect infections and inflammation. December 11, 2013

Trinity Biotech showcases cardiac diagnostic point-of-care system at MEDICA Trinity Biotech showcased its new 15-minute analysis Meritas troponin I (TnI) point-of-care test in Düsseldorf this week. November 20, 2013

Aerotel showcases the smallest handheld ECG monitor at MEDICA Aerotel Medical Systems will showcase two new models of what it claims to be the smallest and most accurate handheld ECG monitor in the world at Medica 2013. November 20, 2013

ARC launches non-contact medical thermometers at MEDICA Belfast company ARC will launch four new high-precision non-contact thermometers at MEDICA this week. November 20, 2013

Capillary Film Technology in MEDICA Biotechnology Developer Capillary Film Technology Ltd (CFT) launched microfluidic device manufacturing technology has announced the launch of new fluoropolymer microcapillary film (MCF) technology. November 20, 2013

Tuberculosis resistance was detected within 15 minutes. QuantuMDx, a diagnostic company based in Newcastle, has received a £1 million grant from the British Technical Strategy Committee to develop a new rapid test method called Q-TB for the diagnosis and detection of tuberculosis Resistance. November 18, 2013

Fetal heart rate monitors use magnetic force to identify abnormal heart rhythms. Devices that record the natural magnetic activity of the fetal heart can help identify abnormal heart rhythms in unborn babies. November 14, 2013

New hope for early detection of pancreatic cancer by blood testing After promising results in a small preliminary study at Johns Hopkins Medical Center in the United States, a simple blood test may be about to emerge to detect pancreatic cancer cells. Gene fragment. November 11, 2013

The new software is 20 times more accurate in detecting genetic diseases. A new computer program developed by the iMinds Institute of Leuven University can quickly identify genetic diseases from a large amount of data generated by genetic analysis. October 30, 2013

Cepheid launches next-generation Xpert Flu diagnostic test Cepheid has launched the next-generation Xpert Flu test for the GeneXpert system, providing on-demand STAT testing for classification, outbreak, emergency and high-risk patient management. October 28, 2013

IBM develops microfluidic probes to diagnose cancer in tissue samples. IBM scientists are working with pathologists at Zurich University Hospital to test a prototype device called a microfluidic probe for accurate diagnosis of different types of cancer. October 28, 2013

Nanodiamonds monitor the molecular processes inside cancer cells. The EU-funded Dinamo project aims to develop a sensing platform that uses fluorescent diamond particles to monitor the biomolecular processes of living cancer cells in real time. October 28, 2013

QuantuMDx won the NE Innovation Award for its handheld DNA sequencer QuantuMDx, a diagnostic company in Newcastle, won the Insider's "Made in Northeast" Life Science Award for its breakthrough handheld DNA sequencer. October 10, 2013

Skuldtech receives 1 million euros for the development of Alzheimer's disease blood biomarker testing French biotech company Skuldtech has received 1 million euros from Bpifrance (French public financing structure) for the development of Alzheimer's disease blood biomarkers test. September 11, 2013

Raman laser highlights tumor cells in brain tissue during surgery. A new laser-based technology can identify cancer cells during surgery, allowing surgeons to ensure that all cells that may develop into new tumors are removed. September 10, 2013

Discoloration Spot Detection of Bloodborne Bacteria A team at the University of Illinois has developed an inexpensive disposable device that contains a chemical sensing array (CSA) that can quickly identify bacteria from the signature chemicals they release. September 10, 2013

Siemens launches SPECT-CT system for high-resolution molecular imaging Siemens Medical’s xSPECT system Symbia Intevo combines the high sensitivity of single photon emission computed tomography (SPECT) with the high specificity of CT to produce high resolution, and for the first time , Quantitative image. August 19, 2013

Rapid tissue analysis revealed that the staging of bowel cancer was fine-tuned for treatment. Researchers at Imperial College used high-resolution magic-angle rotating nuclear magnetic resonance spectroscopy to measure the tumor’s staging by analyzing the chemicals produced by tumor cells. August 15, 2013

RNA test can detect Alzheimer's disease A new RNA-based blood test can distinguish Alzheimer's disease patients from healthy controls. This type of test can be used to help diagnose diseases and other degenerative diseases. July 31, 2013

New breast cancer tests can better diagnose whether chemotherapy is needed. New genetic tests can better determine the likelihood of common breast cancer recurrence and help determine whether chemotherapy is needed. July 2, 2013

Maternal blood test can diagnose fetal Down's syndrome. A non-invasive test that analyzes fetal DNA in pregnant women's blood. It can accurately detect Down's syndrome and other hereditary fetal abnormalities in early pregnancy. June 7, 2013

Microfluidic device separates non-spherical biological particles for rapid disease diagnosis A team from the National University of Singapore (NUS) has developed a new type of microfluidic device that can separate and detect non-spherical biological particles, such as pathogenic bacteria and red blood cells infected with malaria. April 23, 2013

Nanosensors to detect cancer cells The Swiss Nanoscience Institute of the University of Basel and the Ludwig Institute for Cancer Research in Lausanne have developed a nanosensor that can detect cancer cells by identifying mutated RNA. February 27, 2013

Patients are at risk due to inaccurate antibiotic test kits used by hospital pathology laboratories. An investigation by the British Medical Journal (BMJ) found that one of the world's leading manufacturers of diagnostic tests has been mismarketing one of their products. February 13, 2013

The genomics special issue of the Journal of Nurse Nursing Scholarship, which is at the forefront of healthcare genomics, discusses the applications of genes that are essential to advance nursing knowledge and patient care. February 5, 2013

Rapid identification of lung infections by analyzing volatile compounds in the breath The chemical "fingerprints" issued by the lungs infected by specific bacteria can be quickly identified by a mass spectrometry method. January 16, 2013

Q-Cancer received £1.4 million for the development of QuantuMDx benchtop tumor analyzer. The Q-CANCER project will integrate QuantuMDx Group’s rapid laboratory-on-a-chip process and develop the first tumor analyzer in less than 20 minutes. November 23, 2012

A card-sized device can detect diseases from tiny samples in minutes. This card-sized device without a power supply lays the foundation for the early and instant diagnosis of diseases such as cancer and Alzheimer's. November 22, 2012

Blackpool Hospital uses genetic testing to reduce MRSA. The Blackpool Teaching Hospital NHS Foundation Trust has conducted rapid screening of MRSA and MSSA for all emergency admissions and surgical patients admitted through A&E. November 22, 2012

SpinChip microfluidic device analyzes blood at the point of care Norwegian company SpinChip has developed a microfluidic-based chip contained in a portable device that can analyze blood samples at the point of care and provide immediate results. November 14, 2012

DNA sequencing to track the source of MRSA in hospital infections A Cambridge-based team used advanced DNA sequencing technology to confirm in real time whether there is a continuing MRSA outbreak in Cambridge Addenbrooke Hospital. November 14, 2012

Hand-held devices can diagnose influenza strains in minutes. Newcastle-based OJ-Bio has received funding to further develop a device for rapid, simple and low-cost diagnosis of influenza and other viruses. November 13, 2012

Zilico receives a further £750,000 for cervical cancer testing. Zilico Ltd has received a £750,000 investment from the Northwest Biomedical Fund. This follows the £1 million investment announced in June 2012. November 6, 2012

The new "traffic light" test can help general practitioners diagnose liver disease earlier. The Southampton Traffic Light (STL) test combines several different tests and clinical markers. The scores given by these markers indicate that the patient has liver fibrosis and liver Possibility of hardening. September 5, 2012

MedMira won a contract worth 4.2 million US dollars from the US military to commercialize rapid HIV and hepatitis testing. MedMira will promote and commercialize multiple rapid tests. With just a small drop of blood, HIV-1 can be tested simultaneously in three minutes. /2, hepatitis B and hepatitis C antibodies. July 23, 2012

New semen test for testicular cancer Rigshospitalet in Copenhagen has discovered a new simple method that can be tested before testicular cancer starts by detecting markers in sperm samples.

New diagnostic tools increase the value of Kancera's ROR cancer treatment. Kancera and the Karolinska Institute have developed antibodies that allow the development of diagnostic tools to identify cancer patients' response to treatment with Kancera's ROR inhibitors. June 25, 2012

Plessey launches an ultra-low-cost version of the EPIC sensor Plessey Semiconductors has released an ultra-low-cost version of its award-winning EPIC sensor, which provides remote electric field sensing for the high-volume consumer market. June 15, 2012

The miniature magnetic sensor opens a new era of neurology. A new type of magnetic field sensor, called the chip-level atomic magnetometer (CSAM), uses miniature optical devices to measure the absorption changes in the rubidium chamber caused by the magnetic field. June 12, 2012

High-speed benchtop sequencing completely changes hospital infection control. A new generation of benchtop DNA sequencers can quickly and cheaply map the entire genetic code of bacteria that cause life-threatening infections. June 11, 2012

Electronic sensors can detect prostate cancer cells. Scientists at the University of Barcelona have developed the main components of a biosensor. The sensor contains hundreds of nanometer-sized photoacoustic biosensors that can detect cancer cells in urine. June 4, 2012

Enzyme-coated gold nanoparticles can be made into ultra-sensitive disease detectors. Enzyme-coated gold nanoparticles can detect disease biomarkers at concentrations several orders of magnitude lower than current tests, and can detect a series of diseases earlier . May 30, 2012

Stago launches rapid HIT exclusion test in the UK Stago has launched a simple test that can quickly rule out heparin-induced thrombocytopenia (HIT) in just 10 minutes after heparin is used in surgery. May 28, 2012

Abbott awarded the CE mark to the PLEX-ID rapid microbial identification system and clinical testing. PLEX-ID is based on molecular diagnostic technology and addresses the significant unmet need for rapid detection and identification of a wide range of microorganisms that cause infection in patients. May 28, 2012

Idaho Technology's rapid respiratory pathogen detection system received FDA 510(k) approval. Idaho Technology, Inc. has announced that five other pathogens of its FilmArray RP system have received FDA 510(k) approval from the US and launched in the European market. May 28, 2012

Michelson Diagnostics receives 600,000 pounds of investment for further growth Michelson Diagnostics announced that shareholders Octopus Investments, Catapult Venture Managers and London Business Angels will invest a further 607,000 pounds. March 22, 2012

Revolutionary DNA sequencing technology improves the diagnosis of muscular dystrophy. Scientists at the University of Nottingham have used massively parallel DNA sequencing to correctly identify muscular dystrophy diseases. March 7, 2012

Wireless self-driving chips swim in blood vessels. Electrical engineers at Stanford University have developed a miniature, wirelessly powered, self-driving medical device that can control movement through blood vessels. February 27, 2012

PneumaScan installed in Kuala Lumpur Hospital Cambridge company PneumaCare Limited has installed its innovative PneumaScan respiratory assessment equipment in Kuala Lumpur Hospital. February 20, 2012

Using a new genetic test to diagnose influenza virus in record time. The test was developed by researchers at the RIKEN Omics Science Center. It can detect influenza virus infection in 40 minutes with 100 times the sensitivity of traditional methods. February 2, 2012

The X Prize Foundation announced the $10 million prize for the development of Star Trek Tricorder X Prize Foundation and the Qualcomm Foundation have launched the $10 million Qualcomm Tricorder X Prize to stimulate the development of multi-purpose consumer health diagnostic equipment. January 16, 2012

New decision support tools provide early diagnosis of Alzheimer's disease As part of the European PredictAD project, the Finnish VTT Technical Research Center has developed a decision support tool for the objective diagnosis of Alzheimer's disease. January 13, 2012

After visitors received the BioNow Biomedical Award at Medica Microvisk Technologies, Microvisk won the Healthcare Project of the Year. Prior to this, the company's CoagMax and CoagLite equipment achieved great success in Medica. December 9, 2011

Systagenix launches Woundchek Protease Status, a point-of-care test for rapid assessment of chronic wounds. It is the first product produced in collaboration with Alere Scarborough. It is the world's first rapid point-of-care test for evaluating chronic wound protease activity. November 28, 2011

Endomagnetics raises additional funds for new cancer diagnostic probes Endomagnetics in Cambridge has raised a total of 1.8 million pounds. As the business expanded, the company also announced its move to Cambridge and appointed two new appointments. November 23, 2011

Oxford Medical Diagnostics detected 1ppm acetone in breath. Oxford Medical Diagnostics, a spin-off of Oxford University, announced that it has achieved its important goal of developing a cost-effective desktop breath analysis device to diagnose diabetes. November 20, 2011

A new method for detecting breast cancer using magnetic particles and SQUID has developed a new and possibly more sensitive method for detecting breast cancer, which uses tumor-targeted magnetic iron oxide particles and superconducting quantum interference device (SQUID) sensors . October 28, 2011

QuantumDX authorizes nanostructures for DNA sequencing in handheld devices. QuantuMDx Group Limited, headquartered in Newcastle, has signed an exclusive licensing agreement with Nanosys Inc., a developer of nanotechnology in the United States, to obtain a number of patents and patents related to the use of nanostructures in biosensors. patent application. October 23, 2011

Cerebrospinal fluid is the key to the early diagnosis of different types of dementia. Researchers at Sahlgrenska Institute in Sweden found that different forms of dementia leave different biochemical fingerprints in the cerebrospinal fluid before any clinical symptoms appear. October 11, 2011

Max Medical will show a new series of diagnostic and monitoring equipment at Medica 2011. Max Medical will show a series of new products at Medica in Düsseldorf in November, including first aid kits, blood glucose monitoring equipment and blood pressure monitors. September 29, 2011

New aptamer-based sensors will bring cheap, ultra-portable blood testing. The University of Toledo, Ohio has developed a low-cost, portable technology that can quickly and reliably detect specific proteins in human blood samples. September 20, 2011

The University of California, Los Angeles used holograms to create an inexpensive, lightweight lensless microscope. The prototype weighs as much as a medium-sized banana and can be placed in the palm of your hand. It can be used to improve medical care in remote areas of the world, where expensive diagnostic equipment is almost unavailable. September 20, 2011

Microvisk launched the world's first MEMS-based diagnostic system in the United States. Microvisk Technologies, headquartered in North Wales, has launched its handheld device for monitoring the coagulation status of patients in the US market. August 31, 2011

Researchers at Schillerhof Hospital in Germany said that dogs can detect lung cancer from their breath. Sniffer dogs can be used to detect lung cancer early in the patient's breath. August 25, 2011

Simple blood oxygen test can identify newborn babies with dangerous heart defects reason. August 13, 2011

Innovative diagnostic equipment won the NHS smart solution competition. Cardiovascular screening systems using retinal images, new equipment for detecting leg arterial occlusion and neuropathy in diabetic patients, and services that use monitoring equipment to diagnose sleep apnea in patients’ homes are all winners. NHS competition. August 11, 2011

Plessey Semiconductors won the award for its novel electric field sensor technology. The EPIC sensor is a brand new field of sensor technology. The method of measuring electric field changes is similar to that of magnetometers that detect changes in magnetic fields. June 9, 2011

The new marker for prostate cancer provides hope for a more accurate diagnosis than the PSA test. Researchers at Uppsala University have discovered a promising new marker for the diagnosis of prostate cancer. Their unique method can lead to more reliable diagnosis and fewer unnecessary operations. May 18, 2011

Xpert tuberculosis test proved to be fast and effective in developing country settings. A study in the Lancet magazine reported the effectiveness of the Cepheid Xpert MTB/RIF test to detect tuberculosis and rifampicin resistance under actual healthcare field conditions. May 4, 2011

Responding to the growing threat of tuberculosis requires new weapons. Leading experts from 12 countries discussed the growing threat of tuberculosis at a meeting at the Antwerp Institute of Tropical Medicine (ITM) this month. March 28, 2011

The EU-funded new project to find new treatments for tuberculosis is to commemorate World Tuberculosis Day. The European Commission announced its support for new projects aimed at finding new treatments for the disease. March 28, 2011

Bruker launched a portable toxin identification system desktop, push-button pTD system suitable for small, on-site and mobile laboratories for non-professional operators to use in homeland security applications. February 17, 2011

Caliper and Seegene collaborate to provide multiple molecular diagnostic products Caliper Life Sciences, Inc. and Seegene, Inc. have established a strategic partnership to enable Seegene's SeePlex multiple diagnostic analysis to run on Caliper's innovative LabChip Dx platform. January 31, 2011

Caliper launches LabChip Dx for molecular diagnostics. The LabChip Dx system uses the company's proprietary microfluidics technology to develop clinical research laboratories for molecular diagnostic tests. January 31, 2011

Sepmag obtains China's homogeneous biomagnetic separation patent. The company's new technology puts less pressure on the particles and ensures that users always get reproducible results in their in vitro diagnostic kits. January 24, 2011

A mobile platform for rapid sepsis diagnosis The Fraunhofer Institute for Cell Therapy and Immunology is developing a new credit card-sized diagnostic platform that will be able to diagnose sepsis in just one hour. January 6, 2011

Portable devices for breast cancer screening are closer to the market. A new portable device for breast cancer detection based on tissue elasticity has been licensed by a medical device company and has taken a step toward the market. December 10, 2010

DARPA awarded Georgia Institute of Technology US$4.3 million for the development of biochemical sensors. The Defense Advanced Research Projects Agency (DARPA) has awarded Georgia Institute of Technology US$4.3 million for the development of new sensors that can simultaneously detect multiple biological and chemical threats. December 10, 2010

Abbott joins the Clinton Health Initiative to improve HIV testing in Africa. Abbott will provide medical institutions with RealTime HIV-1 qualitative testing kits and the ability to collect and process samples using dried blood spots. November 23, 2010

The high-quality diagnostic testing and manufacturing services exhibited by MEDICA will be exhibited at MEDICA by York-based Forsite Diagnostics this month for contract manufacturing services for lateral flow measurement. November 11, 2010

Your browser does not support iframes or is currently configured to not display iframes.

The Brenmoor PATscan system, a barcode system that correctly recognizes patient samples, can directly copy the patient information in the printed wristband to the label in less than one second, so that hospital samples can be correctly identified. October 25, 2010

Welch Allyn launches a handheld digital blood pressure device to the global market Welch Allyn has launched the Connex ProBP 3400, an automated digital blood pressure device designed for use in the palm of the hand. It provides a portable option that can capture reliable blood pressure readings in almost any hospital or primary care environment. October 21, 2010 Deutsch Français Español

St. George’s Hospital selects MDI’s PCR-based detection method for MRSA screening. Molecular Detection Inc’s Detect-Ready MRSA detection method has been independently verified for the first time in a study conducted by the St. George Healthcare NHS Trust Fund in London, which is currently in progress Use it for screening. October 21, 2010

The British government announced that it will provide 50 million pounds of funds for personalized medicine. The tiered drug innovation platform is a new government plan to provide more than 50 million pounds of funds for personalized medicine diagnosis and drug research and development. October 15, 2010

GATC Biotech is the first in Europe to use the PacBio RS gene sequencer. German gene sequencing service provider GATC Biotech announced that it has agreed to purchase the PacBio RS platform, a single molecule real-time (SMRT) gene sequencing technology. October 11, 2010

Friarage Hospital has improved the workflow of chemical and immunoassay testing. The Friarage Hospital in Yorkshire has installed the UK's first VersaCell sample management system, which incorporates Siemens Healthcare Diagnostics' chemical and immunoassay analyzers. October 11, 2010

LabCorp acquired Genzyme Genetics for US$925 million Laboratory Corporation of America Holdings has agreed to acquire Genzyme Genetics, a business unit of Genzyme Corp and a leading provider of complex reproductive and oncology testing services. September 15, 2010

Launch of the MIRACLE project to develop a lab-on-a-chip for cancer diagnosis​​The EU-funded MIRACLE project was launched on September 1 to develop an operable lab-on-a-chip for the separation and detection of circulating and disseminated tumors in the blood cell. September 3, 2010

Siemens launches a new system for diagnosing and treating heart diseases. Siemens Healthineers presented a series of innovative cardiology solutions at the 2010 European Society of Cardiology. These solutions can provide higher quality care while helping to reduce Health care costs. September 1, 2010

Spartan Bioscience announced the launch of the first point-of-care DNA detection system Spartan RX for personalized medicine. This is a complete sample-to-result, point-of-care DNA detection system for personalized medicine. The non-invasive system provides automatic results within an hour. August 18, 2010

MabCure’s blood test for ovarian cancer received positive results. Cancer diagnosis developer MabCure, Inc. announced that a confirmatory study showed that the company’s proprietary monoclonal antibody (MAb) successfully identified ovarian cancer in the blood (with an accuracy of 94 %), and there is no false positive or cross benign ovarian tumor or healthy blood reaction. August 12, 2010

Aloka's electronic flow technology improves the accuracy of coronary heart disease diagnosis. Compton University of Madrid is using Aloka's electronic tracking technology to advance the early detection of cardiovascular events. This system is used to easily measure the main parameters of arteries and blood vessels. August 2, 2010

BAE Systems won the US Army’s $17 million head-mounted brain injury sensor contract. BAE Systems has received a US Army’s $17 million initial order for its Head Energy Analysis and Diagnostic System (HEADS) to help resolve combat-related issues. Traumatic brain injury. TBI) in Iran and Iraq. July 14, 2010

FDA Approves Tests for Early Diagnosis of AIDS Through HIV Antigens The US FDA has approved an innovative new diagnostic tool from Abbott that can detect AIDS antigens and diagnose AIDS earlier than ever before. July 14, 2010

Computerized blood pressure diagnosis beats hypertension experts. According to an independent study, the computerized system used by the Irish company dabl to diagnose 24-hour blood pressure is more accurate and consistent than the leading international hypertension expert group. June 30, 2010

Ingen launches an in vitro diagnostic kit for joint replacement infection Ingen Bioscience has launched the first in vitro diagnostic kit for detecting prosthesis replacement infection in Europe. The diagnostic kit BJI InoPlex is built around Ingen Biosciences' proprietary antigen technology. June 30, 2010

A simple urine test can diagnose that the chemical fingerprints in the urine of autistic children are different from those of non-autistic children. This discovery may eventually lead to a simple urine test to determine whether the child has autism. June 18, 2010

Ambry Genetics launches a test to identify carriers of neonatal genetic diseases Ambry Genetics launched AmbryScreen, a genetic screening test used to identify carriers of some of the most serious and common childhood diseases that affect pan-ethnic populations. June 14, 2010

The blood test used to detect cancer in diagnostic imaging five years in advance will launch a breakthrough diagnostic test this month that can identify a series of cancer biomarkers in the blood, five years earlier than current diagnostic imaging methods . June 2, 2010

Nano-scale glass conductors used in new laboratory-on-chip equipment found that a new electrical phenomenon that only acts on the nanoscale may lead to faster and cheaper laboratory-on-a-chip diagnostic equipment. May 24, 2010

New rapid point-of-care testing kits bring low-cost diagnosis to HIV and AIDS. Low-cost testing kits that measure CD4 T cells (immune system markers) in blood samples will enable HIV/AIDS patients to obtain antiretroviral drugs faster . May 10, 2010

Nanosensors powered by piezoelectric nanogenerators. By combining a new generation of piezoelectric nanogenerators with two types of nanowire sensors, researchers at Georgia Institute of Technology created what is believed to be the first to obtain energy from conversion The mechanical energy of self-powered nano-scale sensing devices. April 21, 2010

Siemens expanded the Clinitek point-of-care urinalysis product portfolio Siemens Healthcare Diagnostics introduced Clinitek Status+ Analyzer and Clinitek Status Connect systems for urinalysis and pregnancy testing at the point of care. April 2, 2010

Promega Maxwell 16 IVD system has been approved by the European Union Promega Maxwell 16 IVD system has received the CE mark for in vitro diagnostic medical equipment. The CE mark applies to the instrument, Maxwell 16 blood DNA purification system and Maxwell 16 virus total nucleic acid purification system. April 2, 2010

Alliance Biosciences provides HIV and TB biosafety guidance to Kenyan orphanages Alliance Biosciences has reached an agreement with Kenya’s Nyumbani Children’s Home to provide engineering and biosafety guidance for HIV/TB diagnostic facilities in the Nyumbani program. March 9, 2010

Diagnostic Hybrids obtains emergency use authorization for H1N1 influenza A virus ID kit from FDA. This kit is a monoclonal antibody fluorescent staining kit used to specifically identify 2009 H1N1 in direct patient specimens or cultured tissue cultures Influenza A virus. March 9, 2010

Sebia launches Capillarys 2 Flex Piercing for diagnostic laboratories Sebia launched the latest product in its automated capillary electrophoresis product portfolio, the innovative Capillarys 2 Flex Piercing for clinical diagnostic laboratories. March 5, 2010

PositiveID acquires non-invasive blood glucose testing technology through Easy Check PositiveID Corporation has acquired the intellectual property and assets of Easy Check Medical Diagnostics, LLC to expand its product portfolio of non-invasive blood glucose level testing products and diabetes management tools under development. February 23, 2010

The chip used to measure male fertility is the first phase of the home test kit. A new "fertility chip" developed by researchers at the University of Twente is moving towards the development of a reliable "pre-scan" for male fertility. An important step for compact equipment. February 23, 2010

The robot patient helps the students of the University of Bath School of Pharmacy to practice diagnosis. The students of the University of Bath School of Pharmacy are using a robot that can be programmed to have a range of medical conditions from heart disease to constipation to help practice diagnostic skills and treatment patient. February 23, 2010

Femtomedicine-the new frontier of biomedical sciences Femto-neutrons or "femtons" are fast neutrons at the femto-wavelength-one million times smaller than the nanometer scale-and can be used in a new method of rapid cancer diagnosis. February 15, 2010

The antibody-coated nanoparticles in the microfluidic chip increase cancer detection by 100 times. The Fraunhofer Institute for Silicate Research is developing a highly sensitive cancer detection method that can detect cancers associated with specific types of tumors in the blood. Molecular compound. February 5, 2010

The integration of nanotechnology and life science industry: Nano4Life 2010 conference is organized by NanoKTN in cooperation with Wellcome Trust and will be held in London on February 4, 2010

GE develops wearable RFID sensors to detect airborne chemicals GE Global Research has received US$2 million to develop wearable RFID sensors to remind people of the presence of environmental chemicals in the air and signs of disease in exhaled breath. December 9, 2009

Welch Allyn combines diagnostics with electronic connectivity Welch Allyn demonstrated its latest core diagnostic product suite and next-generation electronic connectivity at Medica 2009 in Düsseldorf last week. December 4, 2009

IBM creates a rapid diagnostic test system on a chip. Researchers at the IBM Zurich laboratory have created an instant diagnostic test system based on microfluidics on a silicon chip. The lab-on-a-chip requires fewer samples, is faster, is portable, is easy to use, and can test for a variety of diseases. November 18, 2009

Diagnostic Hybrids obtains FDA approval for influenza A and B virus identification kits Diagnostic Hybrids has announced FDA (510k) approval of its D3 FastPoint L-DFATM Influenza A/B virus identification kits. November 13, 2009

Manhattan Scientifics and Senior Scientifics collaborate to develop a cancer cell detection system Manhattan Scientifics and Senior Scientific, LLC are collaborating to commercialize Senior Scientific's invention of leukemia cancer cell detection based on magnetic needles using nanoparticles. November 12, 2009

Zilico will exhibit a pioneering device for rapid detection of cervical cancer at Medica. The British company Zilico Ltd is exhibiting a pioneering device that can detect cervical cancer faster and more accurately in real time without waiting for several weeks to be diagnosed. First participation in 2009 Medica. November 3, 2009

High-precision analyzers for medical and military applications The revolutionary technology developed by the University of Delaware for the analysis of chemical and biological substances has promise in a variety of applications, from the early detection of diseases to the monitoring of chemical weapons and environmental pollutants . November 3, 2009

The FDA issued guidelines for the development of diagnostic tests for the 2009 H1N1 influenza virus. During the pandemic, manufacturers can submit emergency use authorization requests to the FDA to allow the use of unapproved tests that meet certain standards for diagnosis. November 3, 2009

eBioscience acquired the immunoassay technology of Bender MedSystems eBioscience Corporation acquired the private Austrian pioneer of immunoassay technology Bender MedSystems GmbH in an all-cash transaction. October 27, 2009

High-tech gas sensors used in high-end cars have become diagnostic equipment for human diseases. Researchers at the University of Warwick have used high-tech gas sensors commonly used to test high-end car parts to analyze human blood and urine, and even cow dung samples for testing. The feasibility of their diagnosis of disease. October 28, 2009

Cepheid receives funding to develop ten-color real-time PCR detection technology Cepheid has received a grant notification from the National Institute of Allergy and Infectious Diseases to develop new ten-color detection technology for its GeneXpert system. October 27, 2009

Siemens has won a US$135 million service contract for the US health system. The University of Pennsylvania Health System has awarded Siemens Healthcare a US$135 million integrated service management contract for diagnostic systems and biomedical equipment. October 21, 2009

Breakthrough of laboratory-on-a-chip for rapid detection of breast cancer. The EU-funded MASCOT project has developed a set of modular components for building a laboratory-on-a-chip system for detecting tumor cells in blood samples. These modules are now ready to be integrated into a single lab-on-a-chip and clinical evaluation. October 14, 2009

Claros Diagnostics' point-of-care blood testing system is ISO 13485 certified Ireland (NSAI). October 14, 2009

Using wireless fractional flow reserve technology to measure cardiac blood flow obstruction St Jude Medical, Inc. announced the first use of PressureWire Aeris technology, an interventional tool for measuring the fractional flow reserve (FFR) to assess the severity of cardiac blood flow obstruction. October 13, 2009

Your browser does not support iframes or is currently configured to not display iframes.

Philips develops breakthrough photomultiplier tubes for medical imaging and diagnostics. Royal Philips Electronics (NYSE: PHG, AEX: PHI) announced that its scientists have developed a highly innovative digital silicon photomultiplier tube Technology that will allow faster and more accurate photons (the basic quantum unit of light) to be counted in various applications that require the measurement of ultra-low light levels. October 8, 2009

The Cochrane researchers said that the promising results of the rapid viral diagnostic test in the emergency room. The rapid viral diagnostic test for respiratory diseases in children arriving in the emergency room may reduce the pressure on the health system by enabling doctors to make a diagnosis more quickly. October 5, 2009

The new test can identify active tuberculosis in smear-negative patients. Researchers from the European Tests Group of the Tuberculosis Network found that the enzyme-linked immunospot test (ELISpot) can detect active tuberculosis in patients with negative sputum tests and give the test results within one day. . October 5, 2009

Breast cancer detector with unique touch. Researchers at Drexel University in the United States are developing a new type of portable low-cost breast cancer detector based on piezoelectric fingers that can measure the hardness and mobility of breast tissue. October 5, 2009

UTAS selects ADI Blackfin processor for patient monitoring and diagnostic equipment. UTAS, a manufacturer of patient monitoring and diagnostic equipment, chose ADI’s Blackfin processor to ensure the high-performance digital signal processing operations and powerful functions of its full range of products. October 2, 2009

Cepheid accelerates development of influenza A rapid test kit Cepheid has announced that it has accelerated the development of influenza A test kits for the GeneXpert system. The test is designed to provide a 45-minute identification of influenza A infection and specific presumptive identification of seasonal H1, seasonal H3 and H1N1 new strain types. September 22, 2009

PrimerDesign developed the world's first anti-Tamiflu swine flu test kit. Genetic testing expert PrimerDesign developed a swine flu test kit that can identify anti-Tamiflu virus within 2 hours compared to the usual three days. Strain. September 11, 2009

PerkinElmer launched a variety of steroid diagnostic kits for hormones and endocrine disorders. The Child Health System steroid analysis kit and data suite software can simultaneously measure ten different steroids in biological samples for the diagnosis of hormonal imbalances or endocrine diseases in children and adults . September 10, 2009

Diagnostic Hybrids released Thyretain for the specific detection of Thyroid Stimulating Immunoglobulin. Thyretain is the first test approved by the FDA to specifically detect TSI and will be used to assist the differential diagnosis of Graves' disease (an autoimmune thyroid disease). September 1, 2009

Philips has launched a new ECG PageWriter TC50 ECG with fast diagnostic function to provide intuitive operation and advanced clinical decision support. August 28, 2009

A simple blood test may help predict the risk of Alzheimer's disease. UCLA scientists have discovered a way to measure the amount of amyloid beta absorbed by immune cells in the blood. If the immune system cannot adequately clear amyloid beta, it may indicate a risk of Alzheimer's disease. A diagnostic blood test for public use is currently being developed. August 9, 2009

Laboratory on a chip uses optical detectors to analyze blood The EU-funded NEMOSLAB project is developing an integrated "lab on a chip" that can simultaneously test several different molecules in blood samples at the point of care. July 24, 2009

Luminex launches two new cystic fibrosis tests in Europe. The new xTAG test will be used to help screen neonatal cystic fibrosis and confirm diagnostic tests for neonates and children. These tests can also be used for carrier testing in adults of childbearing age. July 17, 2009

The availability of diagnostic tests drives the success of short-term inpatient wards in hospitals. The most important factor in the successful admission of short-term inpatient wards (SSU) is the type of diagnostic tests performed and whether specialist consultations are required. June 29, 2009

BRNI and Inverness Medical Innovations develop commercial skin tests to detect early Alzheimer's disease Blanchett Rockefeller Neuroscience Institute (BRNI) and Inverness Medical Innovations (Inverness, NYSE: IMA) ) Announced that they will collaborate to further develop and commercialize a diagnostic test for Alzheimer's disease that was first discovered by BRNI scientists. June 18, 2009

Vivacta raised US$4.5 million to commercialize piezoelectric membrane technology for instant diagnostic testing. Vivacta, a diagnostic technology company based in Kent, announced that after successfully developing a thyroid function test, it has completed a round of financing. Current investment The person subscribed in full. June 18, 2009

Siemens developed the RAPID2 system to quickly discover the characteristics of pathogens. The Siemens Research Department developed the RAPID2 system to speed up the biomarker discovery process to develop rapid diagnostic tests. The system combines the power of information technology with genome sequencing to quickly identify the unique genomic characteristics of test organisms. June 16, 2009

The new peptide predicts Alzheimer's disease before the brain is damaged. Researchers at Osaka University in Japan have discovered a peptide in the cerebrospinal fluid (CSF) that can show whether a person is suffering from Alzheimer's disease. Measuring the levels of this peptide can indicate that the disease process has begun, long before any serious damage to the brain is caused and early treatment is allowed. June 10, 2009

Report: The world's top ten in vitro diagnostic companies expect the global in vitro diagnostic (IVD) market to grow at a rate of 6% in 2012, reaching US$50 billion. Roche is the largest player in this market, with a market share of 20%. Following closely behind are Siemens and Abbott, each with a 12% market share. The IVD market is highly integrated, with the top ten participants accounting for nearly 80% of the market share. Recently, many large in vivo manufacturers have entered the in vitro diagnostic market, marking the fusion of the two diagnostic fields. After acquiring DPC, Bayer Diagnostics and Dade Behring, Siemens Healthcare is a prominent example of this trend. more...

PrimerDesign Ltd, a British company based in Southampton that produces the first DNA test kit for Mexican swine flu, said it won the competition to produce the first DNA test kit for Mexican swine flu (H1N1). Compared with the current diagnostic test that takes two days, the rapid test only takes two hours to get results. May 11, 2009

The breast cancer diagnostic proof-of-concept shown by ExonHit's RNA splicing platform Paris-based ExonHit Therapeutics has published a study conducted by Institut Gustave Roussy on Lancet Oncology that describes the analysis of alternative RNA splicing. March 23, 2009

Lab21 acquired Biotec Laboratories Lab21 Ltd of Cambridge, UK, and announced that it has purchased a majority stake in another British company, Biotec Laboratories Ltd, a clinical diagnostic company specializing in infectious diseases. March 10, 2009

The role of the hormone oxytocin in causing autism to study the role of a research team at Stanford University School of Medicine and Lucille Packard Children's Hospital in the United States will test whether the impaired social behavior of autistic patients is related to hormone levels. Preliminary research suggests that autism may be related to oxytocin deficiency March 2, 2009

deCODE Genetics offers low-cost genetic testing for heart risk during February deCODE Genetics offers its deCODEme Cardio Scan, a unique new tool that enables individuals to better understand their heart disease, stroke, and abdominal aorta The genetic risk of heart disease such as tumor, 100 US dollars. February 12, 2009

Non-invasive therapies and diagnosis continue to increase Non-invasive methods are increasing in medical treatment, patient monitoring and diagnosis, because they help to avoid infection and mean to reduce the pain and pressure of patients. February 11, 2009

Sysmex agrees to distribute the AdnaGen cancer diagnostic test in Europe. Sysmex Europe GmbH and AdnaGen AG have signed a non-exclusive European distribution agreement for AdnaGen's proprietary CE certified diagnostic products and their research use (RUO) products. February 10, 2009

Navigenics launches a portal that allows doctors to access patient genomic information. For patients who choose to receive Navigenics services through their doctors, the portal allows doctors to integrate patient genetic information into personalization designed to help early diagnosis or prevent multiple health problems Conditions in the health plan. February 10, 2009

A new type of cheap blood test for hepatitis C A team of multinational researchers has developed a new type of blood test that can bring a breakthrough in the fight against the dangerous hepatitis C virus. This program provides a much cheaper alternative than ordinary commercial tests while maintaining the same sensitivity. February 10, 2009

EXACT Sciences and Genzyme have established a strategic relationship in DNA diagnostic technology. Genzyme acquired prenatal and reproductive health-related intellectual property assets and 3 million shares of EXACT common stock for US$24.5 million. February 9, 2009

The new website demonstrates the advantages of piezoelectric film technology in diagnosis. The new website launched by Vivacta, the developer of the technology, describes the benefits of using piezoelectric film detection technology at the point of care. January 31, 2009

The malaria diagnostic test on the card brings hope to developing countries. Researchers at the University of Washington have developed a prototype malaria test that is printed on a disposable Mylar card the size of a credit card. The key to the test is not only the miniaturized lab-on-a-chip technology, but also the use of sugar to make the dried reagents survive for months without refrigeration. January 26, 2009

Tyrian Diagnostics and Becton, Dickinson and Company completed the feasibility study for tuberculosis diagnosis Tyrian Diagnostics Limited and Becton, Dickinson and Company (BD) completed the feasibility study milestone 4 to determine whether Tyrian’s proprietary tuberculosis (TB) protein marker It is suitable for tuberculosis diagnosis to develop rapid diagnostic test for detecting active tuberculosis. January 22, 2009

MicroPhage successfully completed the Beta test for rapid MRSA detection MicroPhage announced that its new bacterial identification test that can quickly identify MRSA infections has completed its first multi-center clinical trial. The company also reported that the test results exceeded its early performance expectations. January 21, 2009

The much-needed cheap and reliable tuberculosis diagnosis causes 2 million deaths in developing countries every year. Even in Europe and North America, the threat of tuberculosis outbreaks makes these countries spend hundreds of millions of euros every year to control them. However, the immediate and solvable challenge for TB is to diagnose the disease quickly and easily using powerful, well-tested kits. January 8, 2008

In 2008, Germany’s innovative HIV/AIDS diagnostic technology was used 2.5 million times. During 2008, Partec’s CyFlow system has been tested on 2.5 million patients, and the system has provided support to more than 1 million people living with HIV/AIDS. December 17, 2008

The European Union project develops DNA diagnostic equipment for doctors’ desktops. The SMART-BIOMEMS project is developing a microfluidic chip laboratory that can be used in portable diagnostic equipment to automatically analyze various DNA samples at the same time with high precision. December 10, 2008

Chip hospitals can improve the survival rate of the wounded on the battlefield. The goal of American researchers is to develop an implantable biochip that can diagnose and provide medicines to soldiers immediately after they are injured. The survival rate of battlefield wounds usually depends on the level of treatment in the first 30 minutes, so providing immediate treatment to wounded soldiers before the arrival of medical staff can increase the chance of survival. December 8, 2008

Draeger DrugTest 5000 Rapid detection of addictive drugs in saliva Dräger DrugTest 5000 can detect up to six different drug classes in saliva samples within minutes. The system is compact, simple and hygienic in use. It also has data management functions to ensure easy creation of sample documents. November 26, 2008

Philips announces a breakthrough in point-of-care detection using nanotechnology. Philips' new Magnotech technology uses magnetic nanoparticles to measure target molecules. The ease of use and accuracy of this new technology can speed up the diagnosis of life-threatening diseases and bring complex in vitro diagnostic tests from the laboratory to the patient's bedside and home. November 25, 2008

Nanogen cooperates with Menarini to sell molecular diagnostic kits in Europe. According to the agreement, Menarini will commercialize a CE-marked IVD infectious disease kit based on Nanogen's proprietary MGB technology. November 12, 2008

Radal adds NT-proBNP and troponin T to its cardiovascular bedside care product portfolio Radal has added NT-proBNP and troponin T detection to the cardiovascular marker panel, which can be used in care AQT90 FLEX POC immunoassay evaluation platform. November 9, 2008

A landmark 20-year study to assess the impact of personal genetic testing A US consortium is conducting a similar study to evaluate the behavioral impact of personal genetic testing on up to 10,000 people, to understand how it affects their health and determine that they have certain diseases Potential risks. October 14, 2008

BioMérieux develops non-invasive prostate cancer detection French in vitro diagnostic company BioMérieux and German biotechnology company ProteoSys have signed a licensing and development agreement for its new prostate cancer marker Annexin 3, which will be used to develop a urine-based confirmatory diagnosis to detect prostate cancer . October 2, 2008

Enigma Diagnostics awarded £1.8 million for the development of a rapid DNA test for infectious diseases Enigma Diagnostics will develop a "gold standard" portable, rapid, automated DNA analysis (PRADA) molecular test system for decentralized and point-to-point infectious disease diagnosis. Nursing environment such as GP surgery. September 23

Agendia and Ferrer's cancer diagnosis service sales agreement in the European market Agendia BV and Ferrer inCode announced an agreement that will grant Ferrer the exclusive rights to sell Agendia's two iconic cancer diagnosis services in Germany, France, Italy and Portugal. September 17, 2008

Genetic testing can help predict the treatment response of colorectal cancer. The new results show that genetic testing can identify a group of patients with advanced colorectal cancer. If they are treated with the drug cetuximab, the average survival time of these patients may be twice that. September 17, 2008

Fairway Medical Technologies wins a contract for the development of a blood-borne pathogen detector by the U.S. Navy Agents under conditions. September 12, 2008

Report: Molecular Diagnosis. Technology, Market, and Company This best-selling report describes and evaluates molecular diagnostic technologies that will play an important role in the practice of medicine, public health, pharmaceuticals, forensics, and biological warfare in the 21st century. It is aimed at CEOs and chief development officers, and is the most comprehensive and up-to-date one-stop information source for molecular diagnostic technology and business. It includes profiles of 250 companies. September 9, 2008 More...

Report: Instant diagnostic test. World Markets This report describes a specific market segment of the in vitro diagnostics market, called point-of-care testing (POCT). It examines these clinical measurement equipment and their reagents and supplies used in environments close to patients, such as hospitals, clinics, and doctor's offices. The study defines global and U.S. sales, and analyzes the factors that affect the size and growth of market segments. More... September 9, 2008

Breakthroughs in protein microchips may lead to rapid disease detection and drug discovery. Scientists at the University of Manchester have developed a new method of attaching active proteins to biological microchips, which may lead to rapid disease detection and the identification of new drugs. September 8, 2008

Tepnel and SoftGenetics provide rapid analysis of congenital diseases. Tepnel Life Sciences plc and SoftGenetics will market and distribute the SoftGenetics GeneMarker genotyping software, which will be used with Tepnel’s Elucigene QST*R product for prenatal detection of common chromosomal abnormalities, such as Tang Syndrome. August 27, 2008

DNA technology shows high sensitivity for colorectal cancer in stool samples. EXACT Sciences Corporation (NASDAQ: EXAS) announced the results of a study that shows that improved "BEAMing DNA" detection technology is used in the detection of stool samples In colorectal cancer, it has a sensitivity of 92%. August 27, 2008

The University of Twente received 2.4 million euros in funding for point-of-care diagnostics research. The University of Twente, the Netherlands, received a 2.4 million euros funding from the European Research Council for its eLab4Life project, which uses a research laboratory on a chip system for point-of-care diagnostics. August 21, 2008

Lab21 will sell deCODE genetic tests for common diseases in the UK Cambridge company Lab21 Limited has established a partnership with the Icelandic company deCODE Genetics to provide deCODE tests for susceptibility to more and more common diseases. August 13, 2008

Heritage Labs launches a home-use diabetes test kit. American laboratory services company Heritage Labs has launched a home-use test kit for diabetics. Appraise Home A1c Kit is a new household consumer product that can measure the average blood glucose level of diabetic and potential diabetic patients. August 13, 2008

CHAD Therapeutics' sleep diagnostic device Dormio Tech received FDA approval, and a division of CHAD Therapeutics, Inc. has received FDA 510(K) approval to sell its FloChannel diagnostic system in the United States. This is Dormio's first product for the sleep disorder market. August 6, 2008

The discovery of antibodies to cardiovascular disease may result in immunization. Low levels of natural antibodies may represent an increased risk of cardiovascular disease, especially strokes in men. This discovery, published in the journal Atherosclerosis, has now led to attempts to develop immunizations against cardiovascular disease. August 6, 2008

Accurate low-dose drug monitoring is critical to the long-term success of kidney transplantation. Blood tests that can accurately measure the ability of kidney transplant patients to receive very low doses of anti-rejection drugs may have a major impact on ensuring long-term survival and survival rates. According to last week Research report published at the annual meeting of the American Association of Clinical Chemistry (AACC). August 6, 2008

A kit used to quickly assemble the lab-on-a-chip. Engineers at the University of Michigan have developed a kit for researchers to make custom microfluidic devices. The 16-piece lab-on-a-chip kit will bring microfluidic devices to researchers who do not have the funds, technology or skills to design and manufacture microfluidic devices from scratch. August 5, 2008

Abbott has invested another US$20 million in Ibis Biosciences’ biosensor platform. This investment will enable Ibis to further develop the Ibis T5000 biosensor system, which provides a unique feature for the rapid identification and characterization of infectious agents such as bacteria, viruses, and fungi. solution. July 30, 2008

Osmetech has received FDA’s warfarin sensitivity test license. Molecular diagnostic company Osmetech plc’s eSensor warfarin sensitivity test has received 510(k) license from the U.S. Food and Drug Administration to help identify patients at risk. It is widely used The blood thinning drug warfarin. July 30, 2008

BD Obtained EU-approved Diagnostic Test for Clostridium difficile BD Diagnostics' GeneOhm Cdiff molecular test has been approved by the EU for the rapid diagnosis of patients with Clostridium difficile infection (CDI). The test combines high analytical sensitivity with a fast turnaround time of less than two hours. July 16, 2008

Vivacta prepares for trial production of piezoelectric film assay Vivacta is preparing to trial manufacture high-sensitivity disposable piezoelectric film sensors for point-of-care (PoC) diagnosis, gaining an additional 6,000 square feet of space in its facility in Kent Science Park. July 10, 2008

New UV diodes can lead to compact anthrax detectors New UV photodiodes make possible compact, reliable, and cost-effective sensors to detect anthrax and other bioterrorism factors in the air. June 29, 2008

Johnson & Johnson acquired Swedish in vitro diagnostic technology company Amic Johnson & Johnson Nordic AB, a Johnson & Johnson company, acquired Swedish privately held in vitro diagnostic technology developer Amic for use in bedside and near-patient environments. June 19, 2008

Multi-detector CT scan can detect dissolved drugs According to a recent study conducted by the University of Bern, the use of multi-detector CT can reduce the amount of dissolved drugs in bottled liquids, especially the smuggling of cocaine. June 3, 2008

Quest Diagnostics cooperates with Google to provide diagnostic test results online. Doctors can safely provide diagnostic data and a brief description of the test results to the patient’s Google Health account. The system is expected to enable patients and doctors to work more closely together to make more informed healthcare decisions. June 3, 2008

Siemens and LabCorp jointly develop clinical diagnostic tests Siemens Healthcare and LabCorp announced that they are exploring the possibility of jointly developing new clinical diagnostic tests in the areas of companion diagnostics, metabolic syndrome, oncology and diabetes. May 12

Cranfield University is trying a new method of tuberculosis diagnosis through breath test. A project to develop new technology for tuberculosis diagnosis will look for markers released in volatile gases (such as breath) and program the data into existing portable devices (such as Artificial nose) in order to provide a new screening method for rapidly spreading diseases. April 29, 2008

The first 3D image of antibody genes. Scientists at the University of California, San Diego showed for the first time how the genome is organized in 3D space. They used a multidisciplinary combination of geometry, biological research, and technology to solve problems on supercomputers. April 29, 2008

Valdemar Hospital establishes point-of-care testing system Valdemar Private Hospital in Ringsted, Denmark invested in Point-of-Point Testing (POCT) services provided by Capio Diagnostics. The service includes remote monitoring and management of POCT tests in hospitals from Capio Diagnostics' UK monitoring center. April 17, 2008

The Netherlands Institute of Molecular Medicine allocated 150 million euros for disease research. The Center for Translational Molecular Medicine (CTMM) in Eindhoven has allocated 150 million euros to fund 9 research projects that target the most common diseases in the cardiovascular field, cancer and Neurodegenerative diseases. April 7, 2008

Smart clothing with fluid biosensor to monitor health. The textile produced by the European BIOTEX project has a woven micro biosensor that can analyze body fluids such as sweat to assess the health of the wearer. March 31, 2008

The new breast cancer test uses magnetic nanoparticles to detect cancer cells. A team from University College London has developed a new medical device called "HistoMag" that will make early detection of breast cancer more accurate, cost-effective and easier manage. March 10, 2008

Chest distributes Aerocrine Airway Inflammation Tester in Japan Aerocrine AB, a Swedish airway products company, has signed a distribution agreement with Chest MI Inc to market and sell Aerocrine's Niox Mino in Japan. February 20, 2008

The DNA test used to assess the risk of prostate cancer, deCODE Genetics, has launched a test that can identify genetic markers associated with an increased risk of prostate cancer. The company believes that the test will better predict the risk of prostate cancer and help optimize screening and treatment. February 20, 2008

Acrongenomics aims at Molecular Vision's microfluidic bedside diagnostic equipment Acrongenomics, Inc., a Swiss technology investment group, has announced an agreement with Molecular Vision and The Imperial Venture Fund to acquire Molecular Vision at the end of the first quarter of this year. February 15, 2008

Smart holograms help patients to self-diagnose. Patients suffering from chronic diseases such as diabetes, heart disease, kidney disease or hypertension can benefit from the development of new hologram sensors. February 4, 2008

Roche has enhanced its diagnostic capabilities through the acquisition of Ventana Pharmaceutical. The diagnostic company Roche acquired the US diagnostic company Ventana Medical Systems for approximately US$3.4 billion. January 30

The latest advances in genetic knowledge brought about by the personalized medical revolution summit brought by molecular diagnostic technology are changing molecular imaging, molecular diagnostics, and informatics to create extremely accurate diagnostic tools that can evaluate and treat more and more critical diseases. The first international molecular summit to be held from February 5th to 6th will discuss this medical revolution. January 30

Sysmex and bioMérieux established a joint venture company to enter the Japanese diagnostic market. Sysmex Corporation will hold a 34% stake in bioMérieux Japan Ltd. The latter will be renamed Sysmex bioMérieux Co Ltd. The new company will sell bioMérieux in vitro diagnostic products in Japan. January 30, 2008

Quidel and bioMérieux form an alliance in the field of rapid diagnostics Quidel Corporation and bioMérieux have formed an alliance to sell products worldwide, and use Quidel's rapid test development capabilities and bioMérieux's extensive antibody and antigen library to jointly develop new rapid diagnostic tests. January 16

Cepheid launches GeneXpert molecular diagnostic system Cepheid has begun shipping its next-generation GeneXpert independent automated molecular analysis system. It can automate and integrate DNA testing, and can test 60 targets in a single cartridge. January 16

Siemens launched the MicroScan WalkAway plus automated diagnostic system Siemens Medical Solutions Diagnostics launched the MicroScan WalkAway plus system, which is suitable for large and medium-sized clinical diagnostic microbiology laboratories. They can simultaneously automatically test gram-negative bacteria and gram-positive bacteria overnight, fast and professional panels. January 16

BD has been approved for rapid MRSA testing in the European Union and the United States. BD Diagnostics' BD GeneOhm StaphSR has been approved in Europe for detection of MRSA and SA in nasal and wound samples, and has been approved by the US FDA for the detection of positive blood cultures. The test can give results within two hours. January 16

Luminescent molecules to detect prion diseases An international team of researchers has developed a method that uses fluorescent molecules to identify prions and other defective protein diseases. The fluorescent molecules change color according to the existing disease. December 4, 2007

Breakthrough in high-sensitivity tuberculosis and malaria diagnosis The German company Partec has developed a new tuberculosis and malaria diagnosis system suitable for developing countries and remote areas. The system combines Partec's battery-powered and mobile fluorescence microscope with a dedicated test kit developed by Merck. December 4, 2007

Quest Diagnostics obtains FDA approval for blood and herpes immediate testing. Quest Diagnostics Incorporated (NYSE: DGX) announced that its HemoCue and Focus Diagnostics subsidiaries have received FDA 510(k) approval for two new immediate testing kits. Speed ​​up diagnosis time and enable doctors to make treatment decisions immediately. November 21, 2007

New type of sensor can detect bird flu in minutes The new biosensor developed by Georgia Institute of Technology can detect bird flu in minutes. The biosensor is economical, can be deployed on site, is sensitive to different virus strains, and does not require labels or reagents. October 17, 2007

The new laser method helps detect hidden liquid explosives and diseases. Scientists at the Appleton Laboratory in Rutherford, UK have demonstrated a new powerful technology that can detect hidden liquid explosives through ordinary plastic containers and glass bottles. October 8.

Comet spectrometer is designed for tuberculosis. The miniature mass spectrometer system designed to analyze comet samples from the European Space Agency’s Rosetta mission is being transformed into a cost-effective, fast and accurate tool for the diagnosis of tuberculosis (TB). October 8

Gene sequencing confirms that the virus may be the cause of the bee disaster. Researchers at Columbia University and Roche's 454 Life Sciences collaborated to use the company's genome sequencing system to identify a virus related to the death of millions of bee colonies. October 1, 2007

Molecular Vision collaborates to produce diagnostic equipment in Geneva. Molecular Vision Ltd, a branch of Imperial College London, has collaborated with Acrongenomics Inc and design company Pearson Matthews Ltd to develop a real-time medical diagnostic device for the detection of kidney and heart biomarkers. July 4, 2007

Cellestis launches new online service for tuberculosis blood testing. Australian medical diagnostic company Cellestis has created a website to provide global information on the availability of its tuberculosis QFT testing. July 3, 2007

The non-invasive diabetes detector was unveiled at VeraLight Inc. and launched an experimental device that uses light-induced fluorescence to detect diabetes-related biomarkers found in the skin. July 2, 2007

Bacteria put nanoparticles in cells to assist in the diagnosis or treatment of bacteria. The natural infection mechanism of bacteria can be used to deliver nanoparticles carrying drugs, DNA or sensors into cells to achieve precise diagnosis or treatment of diseases. June 19, 2007

DiaGenic develops the Alzheimer's disease blood test. This test uses peripheral blood as an easy-to-collect sample to detect the "gene signature" of the disease. June 11, 2007

Inverness Medical Innovations and Procter & Gamble establish consumer diagnostic companies Inverness Medical Innovations, Inc. and Procter & Gamble Company have completed their previously announced transaction to establish SPD Swiss Precision Diagnostics GmbH, a joint venture for consumer diagnostic products. May 30, 2007

Concentrating virus particles in an electric field may lead to rapid virus detectors. Engineers in the United States have solved the key bottleneck in the transportation and capture of virus nanoparticles, making it possible to quickly sample and detect infectious biological agents (such as viruses). May 9, 2007

The sensor can identify trace samples of cells and proteins within a few minutes. The sensor contains a millimeter-sized cantilever and can be widely used in medical diagnostic tests, food contamination detection, and biological threat agent monitoring.

3M Health Care launches a diagnostic unit for rapid infection detection 3M Health Care has created a new medical diagnostic business unit to develop and commercialize rapid diagnostic products to detect key infectious pathogens such as MRSA and other anti-therapeutic microorganisms. March 28, 2007

Platinum-coated nanotube biosensors detect glucose in near real time. Researchers at the University of Arkansas have created a new type of biosensor that can detect glucose in near real time and has higher sensitivity than other similar biocompatible sensors. March 21, 2007

The BioLED Lab-on-Chip technology will be showcased at Imperial College London. The demonstration version of the BioLED Lab-on-Chip platform that combines microfluidics, organic semiconductor diodes and photodetectors will be shown to selected audiences. February 21, 2007

3M takes over the British rapid diagnostic company Acolyte Biomedica. Joining Acolyte Biomedica enables 3M to expand more quickly into the emerging market of infection prevention and diagnosis, especially in Europe. Acolyte Biomedica has commercial products for MRSA testing. February 20, 2007

By 2016, the global molecular diagnostics market may reach US$92 billion. The market will be driven by the addition of new tests in the field of high-volume testing and the introduction of new instruments that will provide greater convenience, speed and quality. February 15, 2007.

Rapid flu testing reduces antibiotic use According to a study published online in Archives of Internal Medicine, rapid flu testing is associated with a decrease in antibiotic use among hospitalized adults. January 31, 2007

American universities received funding to develop portable devices for detecting avian influenza and bioterrorism pathogens. The Medical College of Wisconsin in Milwaukee received a five-year, $8.1 million research project from the Institute of Allergy and Infectious Diseases (NIAID) of the National Institutes of Health. Funding for the development of a fast, miniaturized, and automated diagnostic device for testing bird flu and most potential bioterrorists. January 23, 2007

Roche Diagnostics launches cobas e 411 immunoassay analyzer Roche Diagnostics has released its next-generation benchtop immunoassay analyzer cobas e 411, which targets the low-to-medium-volume immunoassay market. January 15, 2007

By 2010, the global instant diagnostics market will exceed 16 billion U.S. dollars. According to research by Kalorama Information, the demand for cost reduction and decentralized diagnostic tests in the United States is driving market development. December 18, 2006

Cepheid wins a US$14.9 million contract with the Centers for Disease Control and Prevention for avian influenza virus rapid detector. Cepheid will develop a fully automated, independent test that can detect common forms of influenza virus (A/B influenza) and H5N1 in approximately 30 minutes .December 15, 2006

Siemens’ acquisition of Bayer Diagnostics received European approval. This 4.2 billion euro transaction will enable Siemens to integrate its entire diagnostic imaging, laboratory diagnostics, and clinical information technology value chain under one roof and create what the company claims to be the world’s first. A full-service diagnostic products company. November 3, 2006

Akubio received a grant of 800,000 pounds to develop a handheld electronic disease detector. British nanotechnology company Akubio received a government grant of 826,000 pounds to help develop its rapid detection of viruses and bacteria (such as avian flu, E. coli) , Malaria and meningitis) electronic technology. October 24, 2006

Electronic sensor for detecting Escherichia coli Drexel University is developing a sensor that can detect Escherichia coli within a few minutes by measuring changes in the vibration frequency of the detector. October 24, 2006

BD Biosciences released a flow cytometry system for in vitro diagnostics. September 27, 2006

Disposable glass microchips for large-scale disease screening Researchers in Virginia have developed a disposable microchip that replaces space-consuming instruments with fast, cost-effective laboratory-on-a-chip technology. The microfluidic device is suitable for large-scale screening of disease-related biomarkers. September 20, 2006

Silicon "nano cantilevers" form ultra-sensitive biodetectors. The tiny vibrating silicon structure created by Purdue University researchers will vibrate at different frequencies when pollutants adhere to it, revealing the presence of dangerous substances. September 12, 2006

Bayer Diagnostics launched an immunoassay system. September 8, 2006

The University of Paris studies the medical applications of NanoArrayer The University of Pierre and Marie Curie (UPMC) in Paris is evaluating the BioForce Nanosciences NanoArrayer system. The university will use NanoArrayer to model proteins related to the establishment and migration of cell morphology. August 24, 2006

The United States approves Abbott's fully automated hepatitis blood screening test. Abbott's Prism hepatitis B surface antigen (HBsAg) and Prism HBsAg confirmation test have been approved by the US FDA. These tests can be used to screen donated blood for HBsAg. July 26, 2006

Hepatocytes in silicon crystals screen the toxicity of drugs. Researchers at the University of California, San Diego have developed a "smart petri dish" that can be used to quickly screen the toxic interactions of new drugs or identify cells in the early stages of cancer. The patient's blood. June 20, 2006

The on-chip bird flu virus detector BioWarn has demonstrated the ability to use its new SmartSense system to detect bird flu viruses (H5N1) (also known as bird flu) in real time. This combines biochemistry with silicon chip technology to create a molecular recognition system for pathogens and other materials. June 12, 2006

Nikon launches ultra-sensitive camera for molecular fluorescence imaging Nikon Instruments launched Nikon EMCCD monochrome digital camera (DQC-FS), which is an ultra-high-quality camera designed for single-molecule fluorescence, high-speed calcium imaging, and real-time fluorescence. Designed for horizontal fluorescence. Cellular fluorescent protein imaging. June 7, 2006

Varian has developed a new probe for nuclear magnetic resonance of solid materials. Varian has introduced FastMAS and UltraFastMAS probes for analyzing solid materials and BioStatic probes for determining the molecular structure of proteins and other solid biomolecules. May 6, 2006

Brooke Dalton mass spectrometer obtains Russian medical equipment registration. The complete MALDI-TOF product line of Brooke Dalton mass spectrometer and its ClinProRobot sample preparation platform have been registered. This will enable the Moscow Institute of Physical Chemistry and Medicine to develop a new system to identify and characterize clinically relevant microorganisms. May 1, 2006

Mass spectrometry for the detection of norovirus pathogens in clinical samples. Researchers at Johns Hopkins University have demonstrated that proteomics mass spectrometry may be used to identify viruses in samples from complex environments. It has the potential for biological defense and public health preparation. April 25, 2006

Rapid avian influenza detection kit Applied Biosystems has released its TaqMan influenza A/H5 detection kit for sale in Europe, Asia and Africa. It can quickly and reliably detect a variety of avian influenza virus strains in laboratory samples. March 14, 2006

Bruker Daltonics, a molecular imager for out-of-object imaging of protein biomarkers in tissue sections and cell clusters, launched the MALDI molecular imager for high sensitivity to the spatial distribution of protein biomarkers in biology, pathology, and other clinical research Imaging. March 14, 2006

Hybrid sensor technology revolutionizes high-end spectroscopy Princeton Instruments/Acton has developed hybrid sensor technology that combines the main advantages of CCDS and CMOS sensors to produce a dedicated spectral detector with unparalleled sensitivity and speed. March 13, 2006

Definiens launches an automated image analyzer for cell-based analysis Definiens has released Cellenger, a set of workflow tools and modular components for cell image analysis based on cognitive software developed for remote sensing. February 10, 2006

The molecular diagnostics market is showing rapid growth. Based on its excellent ability to accurately detect the main causes of diseases, molecular diagnostics has become the fastest growing part of the in vitro diagnostics (IVD) industry. January 11, 2006

Nano-scale medical devices can be connected to untwisted DNA strands. Researchers at Ohio State University untie the DNA strands and form them into precise patterns. They can be used as wires for bio-based nanoscale electronics and medical devices. December 18, 2005

The University of Leeds Pathology Unit expands tissue scanning capabilities The University of Leeds Pathology Academic Unit has increased its ability to scan tissue sample slides by purchasing five Aperio ScanScope virtual microscope systems. These will support a wide range of initiatives, including the possibility of initial diagnosis without reference to glass slides. September 7, 2005

Siemens takes over the development of "Lab on a Chip" Siemens is taking over the development of award-winning electrochemical biochips from its project partners. The transfer to Siemens involves patents, high-tech biochip laboratories, and experts with expertise in silicon biochip manufacturing. June 23, 2005